Roivant Sciences (ROIV) revenue

Revenue · fiscal 2026
$8.26M

Roivant Sciences (ROIV) reported revenue of $8.26M in fiscal 2026 (the year ended March 31, 2026). That is 71.6% lower than the $29.05M of fiscal 2025. Figures as of 18 Nov 2026, 06:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2026
$8.26M
Change on fiscal 2025
−71.6%
Growth, 5 years
−19.1% a year
Highest on record
$55.29Mfiscal 2022
Lowest on record
$8.26Mfiscal 2026
Fiscal years on record
62021–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Roivant Sciences revenue, in more detail

Over the five fiscal years to 2026 revenue shrank at a compound 19.1% a year. Across the 6 fiscal years on record (2021–2026), the highest was $55.29M in fiscal 2022 and the lowest $8.26M in fiscal 2026.

History · 6 fiscal years

Revenue by fiscal year

Roivant Sciences revenue, year by year

Roivant Sciences (ROIV) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2026$8.26M 71.6% down
2025$29.05M 11.2% down
2024$32.71M 3.8% up
2023$31.53M 43.0% down
2022$55.29M 132.3% up
2021$23.80M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Roivant Sciences and comparable companies
CompanyRevenueFiscal year
Labcorp Holdings LH$13.95B2025
DexCom DXCM$4.66B2025
Koninklijke Philips PHG€17.83B2025
Roivant Sciences ROIV$8.26M2026
West Pharmaceutical Services WST$3.07B2025
Quest Diagnostics DGX$11.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ROIV

Roivant Sciences, figure by figure

Roivant Sciences (ROIV) overview: price, valuation and scorecardAll health care companies by market value

Roivant Sciences revenue: questions and answers

What is Roivant Sciences's revenue?

Roivant Sciences (ROIV) reported revenue of $8.26M in fiscal 2026 (the year ended March 31, 2026). That is 71.6% lower than the $29.05M of fiscal 2025.

What is the growth rate of Roivant Sciences's revenue?

Over the five fiscal years to 2026 revenue shrank at a compound 19.1% a year.

What are the highest and lowest revenue figures on record for Roivant Sciences?

Across the 6 fiscal years on record (2021–2026), the highest was $55.29M in fiscal 2022 and the lowest $8.26M in fiscal 2026.

How is Roivant Sciences's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Roivant Sciences (ROIV) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ROIV/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.